Get started
Work

[Analysis of the safety and efficacy of 60 mg·m-2·d-1daunorubicin combined with standard dose of cytarabine as induction therapy in acute myeloid leukemia patients under 65 years old].

Year: 2016
Type: article
Abstract: )could improve the rate of complete remission without obvious side effects.
Source: PubMed
DOI: 10.3760/cma.j.issn.0253-2727.2016.10.015
Authors: X X Cao, S J Wang, M H Duan, T N Zhu, W Zhang, B Han, J L Zhuang, H C Cai, M Chen, J Feng, X Han, Y Zhang, C Yang, L Zhang, D B Zhou, J Li
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W2547925038
FWCI:
Cites: 17
Cited by:
Related to: 10